Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended January 31, 2011, for AFH Acquisition X, Inc. (referred to in metadata as Bone Biologics Corp, though the filing identifies the registrant as AFH Acquisition X, Inc.). The company is a Delaware corporation classified as a development stage company and a shell company. Its primary business objective is to pursue a business combination through the acquisition or merger with an existing company. As of the filing date, the company is not conducting negotiations with any target business and has generated no revenue since its inception on October 18, 2007.
Key Financial Metrics
| Metric | Three Months Ended Jan 31, 2011 | Cumulative from Inception (Oct 18, 2007) to Jan 31, 2011 |
|---|---|---|
| Revenue | $0 | $0 |
| Total Expenses | $1,275 | $50,123 |
| Net Loss | $(1,275) | $(50,323) |
| Cash and Cash Equivalents | $0 | $0 |
| Total Assets | $0 | $0 |
| Total Liabilities | $25,323 | $25,323 |
| Stockholder's Deficit | $(25,323) | $(25,323) |
| Shares Outstanding | 5,000,000 | 5,000,000 |
Debt and Liquidity: The company has no cash on hand. Liabilities consist of $4,872 in accrued expenses and $20,451 due to the parent company (AFH Holding & Advisory, LLC). The "Due to Parent" amount represents cash advances with no specified repayment terms.
Material Changes Versus Prior Period
- Net Loss: The net loss for the three months ended January 31, 2011, was $1,275, compared to $787 for the same period in 2010. This increase is primarily attributed to higher legal and professional fees ($1,275 in the current quarter vs. $787 in the prior year quarter).
- Accrued Expenses: Accrued expenses increased from $3,597 at October 31, 2010, to $4,872 at January 31, 2011.
- Cash Position: Cash and cash equivalents remained at $0 for both periods, indicating the company has exhausted its initial capital and relies entirely on parent company advances.
Outlook, Risks, and Management Commentary
- Going Concern: The filing explicitly states that the company's continued existence is dependent upon its ability to raise capital or acquire a marketable company. There is substantial doubt about the company's ability to continue as a going concern without additional funding.
- Plan of Operation: The company intends to locate a target business through solicitation, including advertisements and contacting financial advisors. Management may pay referral fees to consultants upon the consummation of a business combination.
- Risks: There is no assurance the company will locate a target or successfully negotiate a merger. If a non-cash acquisition cannot be effected, the company may need to raise funds via a private offering, which is not guaranteed. Any future acquisition is expected to have a significant dilutive effect on existing shareholders.
- Unusual Items: The company is a shell company with no active operations other than organizational efforts. All expenses incurred to date are related to legal, accounting, and organizational costs.
Investor Verification Checklist
- Capital Adequacy: Verify the company's ability to fund ongoing administrative expenses given the $0 cash balance and reliance on parent company advances.
- Parent Company Relationship: Confirm the terms and repayment status of the $20,451 owed to AFH Holding & Advisory, LLC.
- Acquisition Progress: Investigate if any negotiations with target companies have commenced since the filing date, as none were active as of January 31, 2011.
- Dilution Risk: Assess the potential dilution to the 5,000,000 outstanding shares should the company issue new equity to fund operations or close a merger.
- Legal Status: Confirm the company remains in good standing as a Delaware corporation and has no undisclosed legal proceedings.